Breast biopsy reporting (Histopathological reporting of breast biopsy samples)

What is breast biopsy reporting?

A breast biopsy takes a small sample from a breast lump or area of change, often using a needle. You do not have the reporting done to you; the sample is sent to a laboratory and examined under the microscope by a histopathologist.

Looking at the cells is the most reliable way to tell whether a breast change is harmless (benign) or a cancer. Many breast biopsies are reassuring. The report describes what was found and, in breast units, often uses a simple category system to show how confident the result is.

If cancer is found, further tests are usually done on the sample to guide treatment. These include hormone receptors (oestrogen and progesterone) and a protein called HER2, which help decide which treatments are likely to help.

A breast biopsy report tells you about the sampled area. Tests on a small needle sample usually match the final surgery sample closely, but not always, so some results may be confirmed later. It does not, by itself, show whether a cancer has spread.

Types, options & approaches

There may be different ways to do this. The right approach depends on the clinical question and your circumstances.

What a breast biopsy can and cannot answer

A breast biopsy diagnoses the sampled area; spread is assessed with other tests.

Preparing for your test

• Remember the reporting is done on your sample, not on you, so there is no fasting or anaesthetic for it.
• When the biopsy is taken, ask when and how you will get the result, and who will explain it.
• Most breast units give results at a follow-up clinic; ask whether you can bring someone with you.
• Ask whether receptor or HER2 tests are likely if cancer is found, and how long they add.
• Make sure the team has your history, including any previous breast biopsies or family history.
• If you are paying privately, ask whether the report and a follow-up appointment are included.
• Ask whether your case will be discussed by a breast multidisciplinary team if cancer is found.

What happens

After your breast biopsy, the sample is preserved, labelled and sent to a laboratory. Scientists process it over one or more days, setting it in wax, slicing it thinly, placing it on slides and staining it.

A histopathologist examines the slides under the microscope, decides whether the change is benign or cancer, and often assigns a category showing how confident the result is. If cancer is found, further tests for hormone receptors and HER2 are usually arranged, which can add time.

The pathologist writes a report, which goes to your breast specialist. You are usually given the result at a clinic appointment. Breast cancer cases are discussed at a multidisciplinary team meeting, where pathology, scans and your situation are brought together to plan treatment with you.

Is this test right for me?

A good consultation should explore whether it's the right choice for you now — including reasons to wait or consider something else.

Before you decide

Use this as a shared-decision checklist. The aim is not just “can this be done?”, but whether it is right for you, now, with the risks and alternatives clearly understood.

The main limitations are that the report describes only the sampled area, and that a small needle sample can occasionally differ from the final surgery sample, including receptor and HER2 results. The biopsy does not show whether a cancer has spread. Ask whether the sample was adequate, whether receptor and HER2 results will be confirmed on surgery, and whether your case has been discussed by a breast team.

Published figures to discuss

This is a diagnostic interpretation of tissue already removed, so it does not carry surgical complication rates. The meaningful uncertainty is concordance: receptor and HER2 results from a needle biopsy usually agree closely with the later surgery sample, but not perfectly, so results may be reconfirmed. The figure below is from published studies and is given as a cautious guide, not a promise.

These are literature figures, not a personalised prediction. Your own risks and likely benefits depend on your circumstances, your health, and how your care is carried out and followed up.

What happens afterwards

There is no physical recovery from the reporting itself, because it is done on your sample in a laboratory. Afterwards is about waiting for the report, having it explained, and planning any next steps.

• Feeling anxious while you wait, especially if cancer is possible
• Being given the result at a clinic rather than by phone
• Hearing that receptor and HER2 results will be confirmed later
• Being told scans or lymph node tests are needed to check for spread
• Needing a repeat or larger sample if the first was not enough

Aftercare

• Note when results are expected and chase them if they are late.
• Bring someone with you and ask for the result to be explained clearly.
• If cancer is found, ask about the type, receptors and HER2, and what they mean for treatment.
• Ask whether your case has been discussed by a breast multidisciplinary team.
• Ask what scans or lymph node tests are needed to understand the full picture.
• Find out who your point of contact is, such as a breast care nurse.
• Ask for written information and a copy of your report if you would like one.

• Date of the results clinic written down
• Someone arranged to come with you
• Questions ready about type, receptors and HER2
• Name of your breast care nurse or contact
• A way to access reputable support
• Question ready: has my case been to the team?
• Plan for who chases the result if it is late

⚠ Get urgent help if…

• The biopsy site becomes hot, red, swollen or oozes pus
• Bleeding or a spreading bruise that does not settle
• Severe or worsening breast pain, or feeling generally unwell with a fever
• A rapid change in the breast lump or skin while you wait for results
• Not hearing your result by the date you were given
• Feeling very anxious or low while waiting, so you need extra support

Who to contact: your clinician, clinic or test provider first (keep their number to hand). For urgent advice when you can't reach them, call NHS 111. In an emergency, call 999.

General guidance — it doesn't replace the specific advice your specialist gives you.

Results & realistic expectations

A good outcome is a clear report that says whether the breast change is benign or cancer and, if cancer, gives the type and the receptor and HER2 results needed to plan treatment. Many breast biopsies are reassuring.

When cancer is found, the report guides treatment but does not, by itself, show how far it has spread or guarantee an outcome; that comes from scans, lymph node tests and your team's assessment. Receptor and HER2 results from a small sample are usually accurate, but are sometimes confirmed on the larger surgery sample. Your breast team interprets everything together.

A breast biopsy report describes the sampled area at the time it was taken. The diagnosis itself does not change, but receptor and HER2 results may be confirmed or refined on the surgery sample, and your situation can change, so further tests may be needed. Treatment plans are reviewed as more information becomes available.

Related tests, treatments or support

Breast biopsy reporting usually goes hand in hand with breast imaging, such as mammography and ultrasound, and with tests on the lymph nodes under the arm. If cancer is found, a breast multidisciplinary team brings the pathology, receptor and HER2 results and scans together to plan treatment.

Follow-up & long-term care

Your breast specialist, usually with a breast care nurse, is responsible for giving you the result and explaining what happens next. Expect a cancer case to be discussed by a breast multidisciplinary team and a plan made with you. Ask how and when you will hear, and who to contact in the meantime.

Repeat, follow-on and what comes next

• A repeat or larger sample is sometimes needed when a core biopsy is inconclusive.
• Receptor and HER2 results may be reconfirmed on the surgery sample.
• Specialist second opinions are used for borderline or unusual breast tumours and can change the diagnosis.

Ask what happens if the result is unclear or needs repeating, and what is included if further tests or follow-up are needed.

What good aftercare looks like

• The result explained in person where cancer is found, with time for questions.
• A named contact, such as a breast care nurse, to support you.
• A clear plan for staging scans, lymph node tests and a team discussion.
• Written information and access to reputable support while decisions are made.

What affects the cost

Costs vary a great deal between people and providers, and we don't publish prices. What matters is understanding what drives the cost and making sure your quote is complete. The main things that affect it:

• Whether the laboratory report is included in the price of the biopsy
• The type and number of samples examined
• Whether receptor and HER2 tests are needed
• Whether extra stains or genetic tests are added
• Whether a specialist pathologist or a second opinion is involved
• Whether a results appointment and onward care are included

• Confirmation that the laboratory report is included, not just the biopsy
• The fee for receptor, HER2 or other extra tests
• The cost of a second opinion if you want one
• Whether a results appointment to explain the report is included
• What happens, and what it costs, if a repeat biopsy is needed
• How and when you will receive your result

On the NHS? Breast biopsy reporting is a core NHS service when the sample is taken on the NHS; private reporting may add speed, choice or a second opinion, but there are no prices on this page.

You're entitled to your total cost in writing — including reports, follow-up and what happens if the result is inconclusive — before you decide.

Consent traps and marketing red flags

These are not small details. They are often where patients lose choice, time to reflect, or realistic expectations.

Choosing a specialist safely

• Check the specialist is on the GMC Specialist Register for this area.
• Make sure they work at a CQC-registered service, and look for membership of the relevant Royal College or professional body.
• You're entitled to time to consider and to have your questions answered before you agree — the specialist who looks after you should explain it, not a salesperson.
• Be wary of pressure: time-limited offers or deposits taken before you've had time to think are red flags, not bargains.
• You're entitled to your total cost in writing — including any follow-up — before you decide.

How Vuemedics verifies every consultant →

Take this to your consultation. A good specialist will welcome every one of these.

• Is my result benign or cancer, and how confident is it?
• If cancer, what type is it and what are the receptor and HER2 results?
• Will the receptor and HER2 results be confirmed on the surgery sample?
• Has my case been discussed by a breast multidisciplinary team?
• What scans or lymph node tests are needed to check for spread?
• What happens if the result is unclear or needs repeating?
• Are you on the GMC Specialist Register for this area, and which Royal College or professional body are you a member of?
• Will you be the specialist who carries out my test, and who looks after me afterwards?
• What are the risks for someone like me, and how often do your own patients have a problem or need it repeated or redone?
• What does a realistic result look like — and what can this test not achieve?
• What are my options, including waiting, doing nothing for now, or choosing a different approach?
• Can I have written information, results and aftercare instructions in a format I can use, including any accessibility or communication support I need?
• What is the total cost in writing, including any follow-ups, and how much time do I have to decide?

Find a verified specialist for breast biopsy reporting

Every consultant is GMC-checked and independently reviewed. Search by postcode and distance, or switch to a map. Ordered by rating, relevance and recency — never by who pays.

How we made this page

Medically reviewed by a GMC-registered consultant. Written in plain English, checked against NHS, NICE, GMC and relevant Royal College / specialist-society guidance, and kept under review. No clinic paid to appear on this page, and we publish no pricing. This is general information to help you prepare — it is not a substitute for advice from your own clinician. How we review our guides →

Source hierarchy: UK regulator and NHS/NICE guidance first, then relevant Royal College or specialist-society guidance, then peer-reviewed evidence for procedure-specific figures where available.

Sources & standards: Macmillan Cancer Support — Biopsy Cancer Research UK — Breast cancer stages and grades Royal College of Pathologists — What is a biopsy? NHS — Breast cancer in women Breast Cancer Now — Hormone receptors and breast cancer Core needle versus excision concordance for receptor and HER2 status (PMC review)

Reviews reflect patients' experience of care, not clinical outcomes. For procedure volumes and outcome data see PHIN.

Last medically reviewed 2026-09-21. Spotted something wrong or out of date? Report an error in this guide.